Landucci Elisa, Laurino Annunziatina, Cinci Lorenzo, Gencarelli Manuela, Raimondi Laura
Section of Pharmacology, Department of Health Sciences, University of Florence, Florence, Italy.
Section of Pharmacology, Department of Neurology, Psychology, Drug Sciences and Child Health, University of Florence, Florence, Italy.
Front Cell Neurosci. 2019 Mar 29;13:79. doi: 10.3389/fncel.2019.00079. eCollection 2019.
Mast cells are primary players in immune and inflammatory diseases. In the brain, mast cells are located at the brain side of the blood brain barrier (BBB) exerting a crucial role in protecting the brain from xenobiotic invasion. Furthermore, recent advances in neuroscience indicate mast cells may play an important role in glial cell-neuron communication through the release of mediators, including histamine. Interestingly, brain mast cells contain not only 50% of the brain histamine but also hormones, proteases and lipids or amine mediators; and cell degranulation may be triggered by different stimuli activating membrane bound receptors including the four types of histaminergic receptors. Among hormones, mast cells can store thyroid hormone (T3) and express membrane-bound thyroid stimulating hormone receptors (TSHRs), thus suggesting from one side that thyroid function may affect mast cells function, from the other that mast cell degranulation may impact on thyroid function. In this respect, the research on hormones in mast cells is scarce. Recent pharmacological evidence indicates the existence of a non-genomic portion of the thyroid secretion including thyroid hormone metabolites. Among which the 3,5 diiodothyronine (3,5-T2), 3-iodothyroanamine (T1AM) and 3-iodothyroacetic acid (TA1) are the most studied. All these compounds are endogenously occurring and found to be increased in inflammatory-based diseases involving mast cells. T1AM and TA1 induce, as T3, neuroprotective effects and itch but also hyperalgesia in rodents with a mechanism largely unknown but mediated by the release of histamine. Due to the rapid onset of their effectiveness they may trigger histamine release from a cell where it is "ready-to-be released," i.e., mast cells. Following a very thin path which passes through old experimental and clinical evidence, at the light of novel acquisitions on endogenous T3 metabolites, we aim to stimulate the attention on the possibility that mast cell histamine may be the connector of a novel (neuro) endocrine pathway linking the thyroid with mast cells.
肥大细胞是免疫和炎症性疾病的主要参与者。在大脑中,肥大细胞位于血脑屏障(BBB)的脑侧,在保护大脑免受异源生物入侵方面发挥着关键作用。此外,神经科学的最新进展表明,肥大细胞可能通过释放包括组胺在内的介质,在胶质细胞-神经元通讯中发挥重要作用。有趣的是,脑肥大细胞不仅含有脑内50%的组胺,还含有激素、蛋白酶、脂质或胺类介质;细胞脱颗粒可能由激活膜结合受体(包括四种组胺能受体)的不同刺激引发。在激素方面,肥大细胞可以储存甲状腺激素(T3)并表达膜结合的促甲状腺激素受体(TSHRs),因此一方面表明甲状腺功能可能影响肥大细胞功能,另一方面肥大细胞脱颗粒可能影响甲状腺功能。在这方面,关于肥大细胞中激素的研究很少。最近的药理学证据表明,甲状腺分泌存在非基因组部分,包括甲状腺激素代谢物。其中,3,5-二碘甲状腺原氨酸(3,5-T2)、3-碘甲状腺原胺(T1AM)和3-碘甲状腺乙酸(TA1)是研究最多的。所有这些化合物都是内源性的,并且发现在涉及肥大细胞的炎症性疾病中会增加。T1AM和TA1与T3一样,在啮齿动物中诱导神经保护作用、瘙痒和痛觉过敏,但其机制很大程度上未知,但由组胺释放介导。由于它们起效迅速,可能会从“随时准备释放”组胺的细胞(即肥大细胞)中触发组胺释放。沿着一条非常细微的路径,这条路径贯穿了旧的实验和临床证据,鉴于对内源性T3代谢物的新认识,我们旨在引起人们对肥大细胞组胺可能是连接甲状腺和肥大细胞的新型(神经)内分泌途径的连接物这一可能性的关注。